Vladimir J Cvetković1, Jelena G Najdanović2, Marija Đ Vukelić-Nikolić3, Sanja Stojanović4, Stevo J Najman5. 1. Department of Biology and Ecology, Faculty of Sciences and Mathematics, University of Niš, Višegradska 33, 18000, Niš, Serbia. biovlada@yahoo.com. 2. Institute of Biology and Human Genetics, Faculty of Medicine, University of Niš, dr Zoran Djindjić Boulevard 81, 18000, Niš, Serbia. jella82@gmail.com. 3. Institute of Biology and Human Genetics, Faculty of Medicine, University of Niš, dr Zoran Djindjić Boulevard 81, 18000, Niš, Serbia. marijavukelic@yahoo.com. 4. Institute of Biology and Human Genetics, Faculty of Medicine, University of Niš, dr Zoran Djindjić Boulevard 81, 18000, Niš, Serbia. s.sanja88@gmail.com. 5. Institute of Biology and Human Genetics, Faculty of Medicine, University of Niš, dr Zoran Djindjić Boulevard 81, 18000, Niš, Serbia. stevo.najman@gmail.com.
Abstract
PURPOSE: The osteogenic potential of in vitro osteo-induced adipose-derived mesenchymal stem cells (ADSCs) combined with platelet-rich plasma (PRP) and implanted on bone mineral matrix (BMM) carrier was examined in a subcutaneous model in Balb/c mice. METHODS: In vitro osteogenic differentiation of ADSCs was monitored by relative bone-related gene expression and osteocalcin expression at the third, seventh and 15th day. Test implants consisting of in vitro osteo-induced ADSCs, PRP and BMM (OPC implants) and control implants consisting of PRP and BMM (PC implants) were examined. The relative expression of the bone-related genes encoding osterix, osteocalcin, collagen type I α1 and alkaline phosphatase was examined in implants extracted at one, two, four and eight weeks. Histochemical, immunohistochemical and histomorphometric analyses of implants extracted at two and eight weeks were performed. RESULTS: The highest relative expression of bone-related genes and osteocalcin expression was found at the 15th day of in vitro osteogenic induction of the ADSCs. Permanent and continuous increased expression of bone-related genes was noticed in OPC implants at eight weeks. Expression peaks of bone-related genes in PC implants were at two and four weeks, but they significantly decreased at eight weeks. The signs of resorption, formation of callus-like tissue positive for osteocalcin and increased presence of bone cells were found in OPC implants compared with PC implants. A higher percentage of infiltrated tissue and vascularisation was found in OPC than in PC implants. CONCLUSIONS: The combination of in vitro osteo-induced ADSCs and PRP on BMM carrier represents a promising approach for bone regeneration.
PURPOSE: The osteogenic potential of in vitro osteo-induced adipose-derived mesenchymal stem cells (ADSCs) combined with platelet-rich plasma (PRP) and implanted on bone mineral matrix (BMM) carrier was examined in a subcutaneous model in Balb/c mice. METHODS: In vitro osteogenic differentiation of ADSCs was monitored by relative bone-related gene expression and osteocalcin expression at the third, seventh and 15th day. Test implants consisting of in vitro osteo-induced ADSCs, PRP and BMM (OPC implants) and control implants consisting of PRP and BMM (PC implants) were examined. The relative expression of the bone-related genes encoding osterix, osteocalcin, collagen type I α1 and alkaline phosphatase was examined in implants extracted at one, two, four and eight weeks. Histochemical, immunohistochemical and histomorphometric analyses of implants extracted at two and eight weeks were performed. RESULTS: The highest relative expression of bone-related genes and osteocalcin expression was found at the 15th day of in vitro osteogenic induction of the ADSCs. Permanent and continuous increased expression of bone-related genes was noticed in OPC implants at eight weeks. Expression peaks of bone-related genes in PC implants were at two and four weeks, but they significantly decreased at eight weeks. The signs of resorption, formation of callus-like tissue positive for osteocalcin and increased presence of bone cells were found in OPC implants compared with PC implants. A higher percentage of infiltrated tissue and vascularisation was found in OPC than in PC implants. CONCLUSIONS: The combination of in vitro osteo-induced ADSCs and PRP on BMM carrier represents a promising approach for bone regeneration.
Authors: Arne Mehrkens; Franziska Saxer; Sinan Güven; Waldemar Hoffmann; Andreas M Müller; Marcel Jakob; Franz E Weber; Ivan Martin; Arnaud Scherberich Journal: Eur Cell Mater Date: 2012-09-28 Impact factor: 3.942
Authors: Philippe Bourin; Bruce A Bunnell; Louis Casteilla; Massimo Dominici; Adam J Katz; Keith L March; Heinz Redl; J Peter Rubin; Kotaro Yoshimura; Jeffrey M Gimble Journal: Cytotherapy Date: 2013-04-06 Impact factor: 5.414
Authors: Giuseppe Intini; Sebastiano Andreana; Francesco E Intini; Robert J Buhite; Libuse A Bobek Journal: J Transl Med Date: 2007-03-07 Impact factor: 5.531
Authors: Olga Wittig; Egidio Romano; Cesar González; Dylana Diaz-Solano; Maria Elena Marquez; Pedro Tovar; Rodolfo Aoun; Jose E Cardier Journal: Int Orthop Date: 2016-03-16 Impact factor: 3.075
Authors: Jelena M Živković; Sanja T Stojanović; Marija Đ Vukelić-Nikolić; Milena B Radenković; Jelena G Najdanović; Milan Ćirić; Stevo J Najman Journal: Int Orthop Date: 2020-10-06 Impact factor: 3.075
Authors: Woonhyeok Jeong; Young Seok Kim; Tai Suk Roh; Eun Hye Kang; Bok Ki Jung; In Sik Yun Journal: Childs Nerv Syst Date: 2019-03-16 Impact factor: 1.475
Authors: Christopher J Centeno; Hasan Al-Sayegh; Michael D Freeman; Jay Smith; William D Murrell; Rostyslav Bubnov Journal: Int Orthop Date: 2016-03-30 Impact factor: 3.075
Authors: Jelena G Najdanović; Vladimir J Cvetković; Sanja T Stojanović; Marija Đ Vukelić-Nikolić; Jelena M Živković; Stevo J Najman Journal: World J Stem Cells Date: 2021-01-26 Impact factor: 5.326